Global Iodine Contrast Media Market Report, History and Forecast 2017-2028
Market Analysis and Insights: Global Iodine Contrast Media Market
Due to the COVID-19 pandemic, the global Iodine Contrast Media market size was value at US$ 3,564.19 million in 2021 and is forecast to be a readjusted size of US$ 4,926.37 million by 2028 with a CAGR of 4.39% during the forecast period 2022-2028.
The global main manufacturers of Iodine Contrast Media include GE Healthcare, Bracco Imaging, Bayer, Guerbet Group, Hengrui Medicine, YRPG and BeiLu Pharma, etc. In 2021, the global six largest players have a share approximately 95.26% in terms of revenue.
The North America Iodine Contrast Media market size was US$ 1,087.32 million in 2021, while China was about US$ 745.70 million. The proportion of the China was 20.92% in 2021 and it is predicted that the share will reach 27.79% in 2028, trailing a CAGR of 8.28% through the analysis period. As for the Europe Iodine Contrast Media landscape, Germany is projected to reach US$ 223.23 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 2.58% and 3.85% respectively for the next 6-year period.
Fully considering the economic change by the COVID-19, Iohexol accounting for 31.12% of the Iodine Contrast Media global market in 2021, is projected to value US$ 1,595.55 million by 2028, growing at a revised 5.11% CAGR from 2022 to 2028. While Hospitals segment is altered to an 6.41% CAGR throughout this forecast period and will hold a share about 32.39% in 2028.
Global Iodine Contrast Media Scope and Market Size
The global Iodine Contrast Media market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Iodine Contrast Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
Bayer
GE Healthcare
Bracco Imaging
Bayer
Guerbet Group
Hengrui Medicine
YRPG
BeiLu Pharma
Sanochemia
Imax
Segment by Type
Iohexol
Iodixanol
Iopamidol
Ioversol
Iopromide
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
Korea
India
Taiwan
Southeast Asia
Australia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook